Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Endoscopic Anti-reflux Mucosal Ablation Therapy for Gastroesophageal Reflux Disease: a Single Blind Randomized Sham Controlled Trial

NCT06106100 is registered in ClinicalTrials.gov with Far Eastern Memorial Hospital as lead sponsor.

NCT NCT06106100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06106100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Endoscopic Anti-reflux Mucosal Ablation Therapy for Gastroesophageal Reflux Disease: a Single Blind Randomized Sham Controlled Trial
Lead sponsor
Far Eastern Memorial Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 31, 2024
Completion date
October 31, 2027
Enrollment
68 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease